Cargando…

LC–MS/MS-based in vitro and in vivo investigation of blood–brain barrier integrity by simultaneous quantitation of mannitol and sucrose

BACKGROUND: Understanding the pathophysiology of the blood brain–barrier (BBB) plays a critical role in diagnosis and treatment of disease conditions. Applying a sensitive and specific LC–MS/MS technique for the measurement of BBB integrity with high precision, we have recently introduced non-radioa...

Descripción completa

Detalles Bibliográficos
Autores principales: Noorani, Behnam, Chowdhury, Ekram Ahmed, Alqahtani, Faleh, Ahn, Yeseul, Patel, Dhavalkumar, Al-Ahmad, Abraham, Mehvar, Reza, Bickel, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556948/
https://www.ncbi.nlm.nih.gov/pubmed/33054801
http://dx.doi.org/10.1186/s12987-020-00224-1
_version_ 1783594315987025920
author Noorani, Behnam
Chowdhury, Ekram Ahmed
Alqahtani, Faleh
Ahn, Yeseul
Patel, Dhavalkumar
Al-Ahmad, Abraham
Mehvar, Reza
Bickel, Ulrich
author_facet Noorani, Behnam
Chowdhury, Ekram Ahmed
Alqahtani, Faleh
Ahn, Yeseul
Patel, Dhavalkumar
Al-Ahmad, Abraham
Mehvar, Reza
Bickel, Ulrich
author_sort Noorani, Behnam
collection PubMed
description BACKGROUND: Understanding the pathophysiology of the blood brain–barrier (BBB) plays a critical role in diagnosis and treatment of disease conditions. Applying a sensitive and specific LC–MS/MS technique for the measurement of BBB integrity with high precision, we have recently introduced non-radioactive [(13)C(12)]sucrose as a superior marker substance. Comparison of permeability markers with different molecular weight, but otherwise similar physicochemical properties, can provide insights into the uptake mechanism at the BBB. Mannitol is a small hydrophilic, uncharged molecule that is half the size of sucrose. Previously only radioactive [(3)H]mannitol or [(14)C]mannitol has been used to measure BBB integrity. METHODS: We developed a UPLC–MS/MS method for simultaneous analysis of stable isotope-labeled sucrose and mannitol. The in vivo BBB permeability of [(13)C(6)]mannitol and [(13)C(12)]sucrose was measured in mice, using [(13)C(6)]sucrose as a vascular marker to correct for brain intravascular content. Moreover, a Transwell model with induced pluripotent stem cell-derived brain endothelial cells was used to measure the permeability coefficient of sucrose and mannitol in vitro both under control and compromised (in the presence of IL-1β) conditions. RESULTS: We found low permeability values for both mannitol and sucrose in vitro (permeability coefficients of 4.99 ± 0.152 × 10(−7) and 3.12 ± 0.176 × 10(−7) cm/s, respectively) and in vivo (PS products of 0.267 ± 0.021 and 0.126 ± 0.025 µl g(−1) min(−1), respectively). Further, the in vitro permeability of both markers substantially increased in the presence of IL-1β. Corrected brain concentrations (C(br)), obtained by washout vs. vascular marker correction, were not significantly different for either mannitol (0.071 ± 0.007 and 0.065 ± 0.009 percent injected dose per g) or sucrose (0.035 ± 0.003 and 0.037 ± 0.005 percent injected dose per g). These data also indicate that C(br) and PS product values of mannitol were about twice the corresponding values of sucrose. CONCLUSIONS: We established a highly sensitive, specific and reproducible approach to simultaneously measure the BBB permeability of two classical low molecular weight, hydrophilic markers in a stable isotope labeled format. This method is now available as a tool to quantify BBB permeability in vitro and in vivo in different disease models, as well as for monitoring treatment outcomes.
format Online
Article
Text
id pubmed-7556948
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75569482020-10-15 LC–MS/MS-based in vitro and in vivo investigation of blood–brain barrier integrity by simultaneous quantitation of mannitol and sucrose Noorani, Behnam Chowdhury, Ekram Ahmed Alqahtani, Faleh Ahn, Yeseul Patel, Dhavalkumar Al-Ahmad, Abraham Mehvar, Reza Bickel, Ulrich Fluids Barriers CNS Research BACKGROUND: Understanding the pathophysiology of the blood brain–barrier (BBB) plays a critical role in diagnosis and treatment of disease conditions. Applying a sensitive and specific LC–MS/MS technique for the measurement of BBB integrity with high precision, we have recently introduced non-radioactive [(13)C(12)]sucrose as a superior marker substance. Comparison of permeability markers with different molecular weight, but otherwise similar physicochemical properties, can provide insights into the uptake mechanism at the BBB. Mannitol is a small hydrophilic, uncharged molecule that is half the size of sucrose. Previously only radioactive [(3)H]mannitol or [(14)C]mannitol has been used to measure BBB integrity. METHODS: We developed a UPLC–MS/MS method for simultaneous analysis of stable isotope-labeled sucrose and mannitol. The in vivo BBB permeability of [(13)C(6)]mannitol and [(13)C(12)]sucrose was measured in mice, using [(13)C(6)]sucrose as a vascular marker to correct for brain intravascular content. Moreover, a Transwell model with induced pluripotent stem cell-derived brain endothelial cells was used to measure the permeability coefficient of sucrose and mannitol in vitro both under control and compromised (in the presence of IL-1β) conditions. RESULTS: We found low permeability values for both mannitol and sucrose in vitro (permeability coefficients of 4.99 ± 0.152 × 10(−7) and 3.12 ± 0.176 × 10(−7) cm/s, respectively) and in vivo (PS products of 0.267 ± 0.021 and 0.126 ± 0.025 µl g(−1) min(−1), respectively). Further, the in vitro permeability of both markers substantially increased in the presence of IL-1β. Corrected brain concentrations (C(br)), obtained by washout vs. vascular marker correction, were not significantly different for either mannitol (0.071 ± 0.007 and 0.065 ± 0.009 percent injected dose per g) or sucrose (0.035 ± 0.003 and 0.037 ± 0.005 percent injected dose per g). These data also indicate that C(br) and PS product values of mannitol were about twice the corresponding values of sucrose. CONCLUSIONS: We established a highly sensitive, specific and reproducible approach to simultaneously measure the BBB permeability of two classical low molecular weight, hydrophilic markers in a stable isotope labeled format. This method is now available as a tool to quantify BBB permeability in vitro and in vivo in different disease models, as well as for monitoring treatment outcomes. BioMed Central 2020-10-14 /pmc/articles/PMC7556948/ /pubmed/33054801 http://dx.doi.org/10.1186/s12987-020-00224-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Noorani, Behnam
Chowdhury, Ekram Ahmed
Alqahtani, Faleh
Ahn, Yeseul
Patel, Dhavalkumar
Al-Ahmad, Abraham
Mehvar, Reza
Bickel, Ulrich
LC–MS/MS-based in vitro and in vivo investigation of blood–brain barrier integrity by simultaneous quantitation of mannitol and sucrose
title LC–MS/MS-based in vitro and in vivo investigation of blood–brain barrier integrity by simultaneous quantitation of mannitol and sucrose
title_full LC–MS/MS-based in vitro and in vivo investigation of blood–brain barrier integrity by simultaneous quantitation of mannitol and sucrose
title_fullStr LC–MS/MS-based in vitro and in vivo investigation of blood–brain barrier integrity by simultaneous quantitation of mannitol and sucrose
title_full_unstemmed LC–MS/MS-based in vitro and in vivo investigation of blood–brain barrier integrity by simultaneous quantitation of mannitol and sucrose
title_short LC–MS/MS-based in vitro and in vivo investigation of blood–brain barrier integrity by simultaneous quantitation of mannitol and sucrose
title_sort lc–ms/ms-based in vitro and in vivo investigation of blood–brain barrier integrity by simultaneous quantitation of mannitol and sucrose
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556948/
https://www.ncbi.nlm.nih.gov/pubmed/33054801
http://dx.doi.org/10.1186/s12987-020-00224-1
work_keys_str_mv AT nooranibehnam lcmsmsbasedinvitroandinvivoinvestigationofbloodbrainbarrierintegritybysimultaneousquantitationofmannitolandsucrose
AT chowdhuryekramahmed lcmsmsbasedinvitroandinvivoinvestigationofbloodbrainbarrierintegritybysimultaneousquantitationofmannitolandsucrose
AT alqahtanifaleh lcmsmsbasedinvitroandinvivoinvestigationofbloodbrainbarrierintegritybysimultaneousquantitationofmannitolandsucrose
AT ahnyeseul lcmsmsbasedinvitroandinvivoinvestigationofbloodbrainbarrierintegritybysimultaneousquantitationofmannitolandsucrose
AT pateldhavalkumar lcmsmsbasedinvitroandinvivoinvestigationofbloodbrainbarrierintegritybysimultaneousquantitationofmannitolandsucrose
AT alahmadabraham lcmsmsbasedinvitroandinvivoinvestigationofbloodbrainbarrierintegritybysimultaneousquantitationofmannitolandsucrose
AT mehvarreza lcmsmsbasedinvitroandinvivoinvestigationofbloodbrainbarrierintegritybysimultaneousquantitationofmannitolandsucrose
AT bickelulrich lcmsmsbasedinvitroandinvivoinvestigationofbloodbrainbarrierintegritybysimultaneousquantitationofmannitolandsucrose